Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Organic Chemistry >  Heterocyclic Compounds >  8-BROMO-2-CHLOROQUINAZOLINE

8-BROMO-2-CHLOROQUINAZOLINE

Basic information Safety Supplier Related

8-BROMO-2-CHLOROQUINAZOLINE Basic information

Product Name:
8-BROMO-2-CHLOROQUINAZOLINE
Synonyms:
  • 8-BROMO-2-CHLOROQUINAZOLINE
  • 8-BroMo-2-chloroquinazoli...
  • 8-Bromo-2-chloroquinazoline 97%
  • 2-chloro-8-bromoquinazoline
  • Quinazoline, 8-bromo-2-chloro-
CAS:
956100-63-3
MF:
C8H4BrClN2
MW:
243.49
Product Categories:
  • CHIRAL CHEMICALS
Mol File:
956100-63-3.mol
More
Less

8-BROMO-2-CHLOROQUINAZOLINE Chemical Properties

Boiling point:
309.7±24.0 °C(Predicted)
Density 
1.762
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
-1.09±0.30(Predicted)
Appearance
Yellow to orange Solid
More
Less

Safety Information

Risk Statements 
41
Safety Statements 
26-39
RIDADR 
UN2811
HazardClass 
IRRITANT
HS Code 
2933998090
More
Less

8-BROMO-2-CHLOROQUINAZOLINE Usage And Synthesis

Synthesis

956100-62-2

956100-63-3

General procedure for the synthesis of 8-bromo-2-chloroquinazoline from 4-amino-8-bromo-2-chloroquinazoline: 8-bromo-2-chloroquinazolin-4-amine (12.93 g, 50 mmol) was dissolved in THF (500 mL) under stirring conditions, and isoamyl nitrite (23.43 g, 200 mmol) was added slowly dropwise over a dropwise period of 3 hours. Subsequently, the reaction mixture was continued to be stirred at 60 °C for 40 min. Upon completion of the reaction, the progress of the reaction was monitored by TLC (unfolding agent: PE:EA = 1:1). When the reaction was complete, the mixture was cooled to room temperature and the solvent was removed by distillation under reduced pressure. The residue was dissolved in DCM (300 mL) and the organic layer was washed sequentially with brine (100 mL) and water (100 mL). The organic layer was dried over anhydrous Na2SO4 and purified by column chromatography (eluent: DCM:PE = 1:1) to afford the target compound 8-bromo-2-chloroquinazoline as a yellow solid (8.21 g, 67% yield).1H NMR (DMSO-d6, 400 MHz): δ 9.66 (s, 1H), 8.45 (dd, J = 0.8, 7.6 Hz, 1H), 8.26 (dd, J = 0.8, 8.0 Hz, 1H), 7.73 (dd, J = 7.6, 8.0 Hz, 1H).

References

[1] Patent: WO2007/125405, 2007, A2. Location in patent: Page/Page column 25; 81-82
[2] Patent: EP3287463, 2018, A1. Location in patent: Paragraph 0191; 0195
[3] Patent: WO2015/27222, 2015, A2. Location in patent: Paragraph 0216
[4] Patent: US2018/208604, 2018, A1. Location in patent: Paragraph 0484-0485

8-BROMO-2-CHLOROQUINAZOLINESupplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
ChemFuture PharmaTech (Jiangsu) Ltd
Tel
5108538618
Email
suger.wang@chemfuture.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
Carbott PharmTech Inc.
Tel
0535-6385396
Email
info@carbottpharm.com